mhurhangee/patent-ind-claim-en huggingface dataset:
A solder alloy comprising: tin, silver, copper, bismuth, antimony, indium, nickel, and inevitable impurities, wherein with respect to the total amount of the solder alloy, the content ratio of the silver is 0.05 mass% or more and below 0.2 mass%; the content ratio of the copper is 0.1 mass% or more and 1 mass% or less; the content ratio of the bismuth is 4.1 mass% or more and 10 mass% or less; the content ratio of the antimony is 0.005 mass% or more and 8 mass% or less; the content ratio of the indium is 0.005 mass% or more and 2 mass% or less; the content ratio of the nickel is 0.003 mass% or more and 0.4 mass% or less; and the content ratio of the tin is the remaining ratio and the mass ratio (Bi/Ni) of the bismuth content with respect to the nickel content is 35 or more and 1500 or less, wherein the solder alloy optionally comprises cobalt, wherein the content ratio of the cobalt is 0.001 mass% or more and 0.1 mass% or less, wherein the solder alloy optionally comprises: at least one element selected from the group consisting of germanium, gallium, iron, and phosphorus, wherein the content ratio of the element with respect to the total amount of the solder alloy is above 0 mass% and 1 mass% or less. tin, silver, copper, bismuth, antimony, indium, nickel, and inevitable impurities, wherein with respect to the total amount of the solder alloy, the content ratio of the silver is 0.05 mass% or more and below 0.2 mass%; the content ratio of the copper is 0.1 mass% or more and 1 mass% or less; the content ratio of the bismuth is 4.1 mass% or more and 10 mass% or less; the content ratio of the antimony is 0.005 mass% or more and 8 mass% or less; the content ratio of the indium is 0.005 mass% or more and 2 mass% or less; the content ratio of the nickel is 0.003 mass% or more and 0.4 mass% or less; and the content ratio of the tin is the remaining ratio and the mass ratio (Bi/Ni) of the bismuth content with respect to the nickel content is 35 or more and 1500 or less, wherein the solder alloy optionally comprises cobalt, wherein the content ratio of the cobalt is 0.001 mass% or more and 0.1 mass% or less, wherein the solder alloy optionally comprises: at least one element selected from the group consisting of germanium, gallium, iron, and phosphorus, wherein the content ratio of the element with respect to the total amount of the solder alloy is above 0 mass% and 1 mass% or less. at least one element selected from the group consisting of germanium, gallium, iron, and phosphorus, wherein the content ratio of the element with respect to the total amount of the solder alloy is above 0 mass% and 1 mass% or less.
A long-acting muscarinic antagonist (LAMA) or a pharmaceutically acceptable salt of the cation thereof for the use in a method of treating an airway disease in an equine, preferably a horse, wherein the LAMA is a compound of the general formula: wherein A denotes a double-bonded group selected from among X - denotes an anion with a single negative charge, R 1 and R 2 denote C 1 -C 4 -alkyl, which may optionally be substituted by hydroxy or halogen; R 3 , R 4 , R 5 and R 6 , which may be identical or different, denote hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkyloxy, hydroxy, CF3, CN, NO2 or halogen; R7 denotes hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylene-halogen, halogen- C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylene-OH, CF3, -C 1 -C 4- alkylene- C 1 -C 4 -alkyloxy, -O-COC 1 -C 4 -alkyl, -O-COC 1 -C 4 -alkyl-halogen, -O-COCF 3 or halogen, optionally in the form of the individual optical isomers, mixtures of the individual enantiomers or racemates thereof, while if A denotes R 1 and R 2 denote methyl and R 3 , R 4 , R 5 and R 6 denote hydrogen, R 7 cannot also be hydrogen, preferably the LAMA is a compound of the formula (LAMA 1): A denotes a double-bonded group selected from among X - denotes an anion with a single negative charge, R 1 and R 2 denote C 1 -C 4 -alkyl, which may optionally be substituted by hydroxy or halogen; R 3 , R 4 , R 5 and R 6 , which may be identical or different, denote hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkyloxy, hydroxy, CF3, CN, NO2 or halogen; R7 denotes hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylene-halogen, halogen- C 1 -C 4 -alkyloxy, C 1 -C 4 -alkylene-OH, CF3, -C 1 -C 4- alkylene- C 1 -C 4 -alkyloxy, -O-COC 1 -C 4 -alkyl, -O-COC 1 -C 4 -alkyl-halogen, -O-COCF 3 or halogen, optionally in the form of the individual optical isomers, mixtures of the individual enantiomers or racemates thereof, R 1 and R 2 denote methyl and R 3 , R 4 , R 5 and R 6 denote hydrogen, R 7 cannot also be hydrogen,
A method of assembling plates, comprising the following steps: • cutting a first metal plate having a thickness of at least 3 mm such as to form an edge from which rectangular cross-section studs extend; • cutting slots associated with the studs in a second plate having a thickness less than the length of the studs ; • applying the first plate perpendicularly to the second while inserting the studs into the slots ; characterised in that the method further includes the following step: • striking the distal ends of the studs projecting from the second plate to form rivet heads resting on the perimeters of the slots . • cutting a first metal plate having a thickness of at least 3 mm such as to form an edge from which rectangular cross-section studs extend; • cutting slots associated with the studs in a second plate having a thickness less than the length of the studs ; • applying the first plate perpendicularly to the second while inserting the studs into the slots ; • striking the distal ends of the studs projecting from the second plate to form rivet heads resting on the perimeters of the slots .
Setting device for driving fastening elements in a setting direction into a substrate, having a driving-in element , which is movable back and forth between a starting position and a setting position, having a drive, which is provided to drive the driving-in element from the starting position to the setting position in the setting direction in order to transmit energy to a fastening element, and having a recessing device , which is provided to convey the driving-in element from the setting position to the starting position counter to the setting direction, wherein the recessing device comprises a rotor , which is rotatable about an axis of rotation, and a driver element , which is mounted on the rotor and which can be brought into engagement with the driving-in element in order to drive the driving-in element along counter to the setting direction, wherein the driver element is mounted on the rotor so as to be movable radially with respect to the axis of rotation such that the driver element moves away from the axis of rotation during rotation of the rotor in order to come into engagement with the driving-in element , characterized in that the recessing device comprises a spring which acts between the rotor and the driver element and loads the driver element towards the axis of rotation.
A compound of Formula (I) or a tautomer, stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt, or hydrate thereof: wherein: X 1 and X 2 are each independently selected from C(R 3 ) 2 , NR 4 , O, S, cycloalkyl, aryl, heterocycle, and heteroaryl, each of which is independently substituted with 0, 1, 2, or 3 R 5 ; A is selected from: B is selected from wherein represents the point of attachment of B to A; L* is a linker of 1 to 22 carbon atoms in length, wherein one or more carbon atoms are each optionally and independently replaced by a group selected from C(O), O, NR 4 , S, C 2 -alkenyl, C 2 -alkynyl, cycloalkyl, aryl, heterocycle, and heteroaryl, each of which is substituted with 0, 1, 2, or 3 R 5 ; R 1 and R 2 are each independently selected from H or OH; each R 3 is independently selected from H, C 1 -C 6 alkyl, halo, and hydroxy; each R 4 is independently selected from H, C 1 -C 6 alkyl, and acyl, each of which is substituted with 0, 1, 2, or 3 R 5 ; and each R 5 is independently selected from C 1 -C 6 alkyl, halo, cyano, and hydroxy, wherein represents the point of attachment of A to X 2 . X 1 and X 2 are each independently selected from C(R 3 ) 2 , NR 4 , O, S, cycloalkyl, aryl, heterocycle, and heteroaryl, each of which is independently substituted with 0, 1, 2, or 3 R 5 ; A is selected from: B is selected from wherein represents the point of attachment of B to A; L* is a linker of 1 to 22 carbon atoms in length, wherein one or more carbon atoms are each optionally and independently replaced by a group selected from C(O), O, NR 4 , S, C 2 -alkenyl, C 2 -alkynyl, cycloalkyl, aryl, heterocycle, and heteroaryl, each of which is substituted with 0, 1, 2, or 3 R 5 ; R 1 and R 2 are each independently selected from H or OH; each R 3 is independently selected from H, C 1 -C 6 alkyl, halo, and hydroxy; each R 4 is independently selected from H, C 1 -C 6 alkyl, and acyl, each of which is substituted with 0, 1, 2, or 3 R 5 ; and each R 5 is independently selected from C 1 -C 6 alkyl, halo, cyano, and hydroxy, wherein represents the point of attachment of A to X 2 .
An apparatus comprising: an implantable medical lead having a proximal contact and a distal electrode ; a sheath containing a shield layer positioned about the implantable medical lead between the proximal contact and the distal electrode, wherein the shield layer is configured to provide shielding from high energy radio frequency energy during a magnetic resonance imaging; and an anchoring structure holding the sheath in a fixed position about the implantable medical lead . an implantable medical lead having a proximal contact and a distal electrode ; a sheath containing a shield layer positioned about the implantable medical lead between the proximal contact and the distal electrode, wherein the shield layer is configured to provide shielding from high energy radio frequency energy during a magnetic resonance imaging; and an anchoring structure holding the sheath in a fixed position about the implantable medical lead .
An electronic device comprising at least one processor configured to: - identify a dynamic light scene to be rendered, wherein identifying the dynamic light scene comprises one of receiving the light scene itself, receiving an identifier that allows the light scene to be retrieved or receiving one or more light commands, - determine a color and/or light level of a current light scene (91-98) for one or more lights (21-23), characterized in that the at least one processor is further configured to: - determine a target dynamic light scene (83-87) by adjusting said identified dynamic light scene based on the determined color and/or light level of the current light scene (91-98), and - render said target dynamic light scene (83-87) on at least one light of the one or more lights. - identify a dynamic light scene to be rendered, wherein identifying the dynamic light scene comprises one of receiving the light scene itself, receiving an identifier that allows the light scene to be retrieved or receiving one or more light commands, - determine a color and/or light level of a current light scene (91-98) for one or more lights (21-23), characterized in that the at least one processor is further configured to: - determine a target dynamic light scene (83-87) by adjusting said identified dynamic light scene based on the determined color and/or light level of the current light scene (91-98), and - render said target dynamic light scene (83-87) on at least one light of the one or more lights.
A tubular reactor with a fixed bed which extends, according to a longitudinal axis XX', between a first end and a second end , said reactor comprises a catalytic powder bed confined within an annular space delimited by a first wall of a hollow tube and a second wall of a hollow insert , disposed in the hollow tube and coaxially with the latter, the hollow insert comprises at least one distribution chamber and at least one collection chamber , separated from each other by a splitting wall , and comprising, respectively, a gas intake opening at the first end and a gas evacuation opening at the second end , the second wall comprises at least one distributing opening and at least one collecting opening , which extend over a length L, the distributing opening allowing the distribution of a gas that could be drawn by the intake opening of the distribution chamber towards the annular space , and the collecting opening allowing the collection of the gas distributed in the annular space by the collection chamber . said reactor comprises a catalytic powder bed confined within an annular space delimited by a first wall of a hollow tube and a second wall of a hollow insert , disposed in the hollow tube and coaxially with the latter, the hollow insert comprises at least one distribution chamber and at least one collection chamber , separated from each other by a splitting wall , and comprising, respectively, a gas intake opening at the first end and a gas evacuation opening at the second end , the second wall comprises at least one distributing opening and at least one collecting opening , which extend over a length L, the distributing opening allowing the distribution of a gas that could be drawn by the intake opening of the distribution chamber towards the annular space , and the collecting opening allowing the collection of the gas distributed in the annular space by the collection chamber .
System comprising: • one first tag (ET 1 ) comprising a graphic code (CG 1 ), • a UWB radio transmitter device (EM 1 ) comprising a UWB radio transmission module of a UWB signal and a UHF radio reception module to collect signals in order to electrically power the UWB transmission module, • a pairing device (D A ) comprising a reader of said first graphic code (CG 1 ) and a UWB receiver to receive the UWB signal transmitted by the transmitter device (EM 1 ), said pairing device (D A ) comprising a memory to save a pair of values comprising a data specific to the graphic code (CG 1 ) and a data specific to the UWB signal received, said transmitter device (EM 1 ) comprising a support comprising a zone delimiting a geometric contour making it possible to visually read the graphic code (CG 1 ) of the first tag (ET 1 ) when the transmitter device (EM 1 ) is superimposed on the first tag (ET 1 ). • one first tag (ET 1 ) comprising a graphic code (CG 1 ), • a UWB radio transmitter device (EM 1 ) comprising a UWB radio transmission module of a UWB signal and a UHF radio reception module to collect signals in order to electrically power the UWB transmission module, • a pairing device (D A ) comprising a reader of said first graphic code (CG 1 ) and a UWB receiver to receive the UWB signal transmitted by the transmitter device (EM 1 ), said pairing device (D A ) comprising a memory to save a pair of values comprising a data specific to the graphic code (CG 1 ) and a data specific to the UWB signal received,
A head-mounted display comprising: a display unit having a display for displaying graphical content to a user; and a facial interface coupled to the display unit and configured to engage a face of the user to support the display unit thereon, the facial interface having an upper portion that engages a forehead of the user and side portions that engage temple regions of the user, wherein the facial interface transfers forward force applied to the upper portion by the forehead into inward force applied by the side portions to the temple regions, wherein the facial interface includes a force distributor having an upper segment that forms the upper portion and two side segments that form the side portions, wherein forward movement of the upper segment causes inward movement of the side segments, and wherein the facial interface includes supports , characterised in that the force distributor is pivotable about the supports for the upper segment to move forward and the side segments to move inward. a display unit having a display for displaying graphical content to a user; and a facial interface coupled to the display unit and configured to engage a face of the user to support the display unit thereon, the facial interface having an upper portion that engages a forehead of the user and side portions that engage temple regions of the user, wherein the facial interface transfers forward force applied to the upper portion by the forehead into inward force applied by the side portions to the temple regions, wherein the facial interface includes a force distributor having an upper segment that forms the upper portion and two side segments that form the side portions, wherein forward movement of the upper segment causes inward movement of the side segments, and wherein the facial interface includes supports , characterised in that the force distributor is pivotable about the supports for the upper segment to move forward and the side segments to move inward.
A combination comprising: an inulin, a galacto-oligosaccharide, a polydextrose and a water-insoluble dietary fibre, in which a weight ratio of the inulin, the galacto-oligosaccharide, the polydextrose and the water insoluble dietary fibre is 10 to 30:5 to 30:10 to 40:10 to 50, the combination being for use as an anti-inflammatory medicament for reducing blood lead.
A vaporizer comprising: a liquid storage for storing liquid composition; an upper cap portion coupled with the liquid storage and having a cavity for introducing the liquid composition of the liquid storage ; a lower cap portion coupled with the upper cap portion to form an aerosol-generating space; a liquid delivery element positioned in the aerosol-generating space between the upper cap portion and the lower cap portion , and configured to absorb the liquid composition transferred from the liquid storage ; a sealing portion having a coupling recess supporting at least one of end portions of the liquid delivery element , positioned between the upper cap portion and the lower cap portion , connected to the cavity , and configured to deliver the liquid composition from the liquid storage to the at least one of the end portions of the liquid delivery element ; a heating element configured to heat the liquid delivery element to generate aerosol; and a leg portion extending from the upper cap portion to the lower cap portion , contacting at least a portion of the liquid delivery element , and configured to block a coupled portion between the coupling recess of the sealing portion and the at least one of the end portions of the liquid delivery element to block a flow of the liquid composition from the sealing portion to the aerosol-generating space. a liquid storage for storing liquid composition; an upper cap portion coupled with the liquid storage and having a cavity for introducing the liquid composition of the liquid storage ; a lower cap portion coupled with the upper cap portion to form an aerosol-generating space; a liquid delivery element positioned in the aerosol-generating space between the upper cap portion and the lower cap portion , and configured to absorb the liquid composition transferred from the liquid storage ; a sealing portion having a coupling recess supporting at least one of end portions of the liquid delivery element , positioned between the upper cap portion and the lower cap portion , connected to the cavity , and configured to deliver the liquid composition from the liquid storage to the at least one of the end portions of the liquid delivery element ; a heating element configured to heat the liquid delivery element to generate aerosol; and a leg portion extending from the upper cap portion to the lower cap portion , contacting at least a portion of the liquid delivery element , and configured to block a coupled portion between the coupling recess of the sealing portion and the at least one of the end portions of the liquid delivery element to block a flow of the liquid composition from the sealing portion to the aerosol-generating space.
A pharmaceutical composition comprising an effective amount of 6-ethyl-chenodeoxycholic acid or tauro-6-ethyl-chenodeoxycholic acid and an inert and pharmaceutically acceptable carrier for use in a method of inhibiting liver fibrosis associated with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) in a subject not suffering from a cholestatic condition.
A communication device functioning as a master device constituting a part of a programmable logic control system, the master device being communicably connectable to a plurality of slave devices via a communication line , the communication device comprising: a setting unit configured to set a prescribed address in an added slave device based on a position of the added slave device in a topology that is composed of a plurality of the slave devices ; characterized by further comprising: a judging unit configured to judge whether a change has possibly occurred in the topology when the prescribed address is set in the added slave device by the setting unit; a specifying unit configured to, if there is an erroneously set slave device whose address was erroneously set by the setting unit, specify the erroneously set slave device , when it is judged by the judging unit that a change has possibly occurred; and a resetting unit configured to reset the address of the erroneously set slave device specified by the specifying unit to an original address. a setting unit configured to set a prescribed address in an added slave device based on a position of the added slave device in a topology that is composed of a plurality of the slave devices ; characterized by further comprising: a judging unit configured to judge whether a change has possibly occurred in the topology when the prescribed address is set in the added slave device by the setting unit; a specifying unit configured to, if there is an erroneously set slave device whose address was erroneously set by the setting unit, specify the erroneously set slave device , when it is judged by the judging unit that a change has possibly occurred; and a resetting unit configured to reset the address of the erroneously set slave device specified by the specifying unit to an original address. a judging unit configured to judge whether a change has possibly occurred in the topology when the prescribed address is set in the added slave device by the setting unit; a specifying unit configured to, if there is an erroneously set slave device whose address was erroneously set by the setting unit, specify the erroneously set slave device , when it is judged by the judging unit that a change has possibly occurred; and a resetting unit configured to reset the address of the erroneously set slave device specified by the specifying unit to an original address.